balsalazide disodium

FDA Drug Profile — balsalazide disodium

Drug Details

Generic Name
balsalazide disodium
Brand Names
balsalazide disodium
Application Number
ANDA217592
Sponsor
Zydus Pharmaceuticals (USA) Inc.
NDC Codes
3
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
BALSALAZIDE DISODIUM

Indications and Usage

1 INDICATIONS AND USAGE Balsalazide disodium capsules are indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Limitations of Use Safety and effectiveness of balsalazide beyond 8 weeks in pediatric patients 5 years to 17 years of age and 12 weeks in adults have not been established. Balsalazide is an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. ( 1 ) Limitations of Use: Safety and effectiveness of balsalazide beyond 8 weeks in children (ages 5 to 17 years) and 12 weeks in adults have not been established. ( 1 )